First global trial now testing new treatment for chronic cough in IPF

According to its U.S. developer, the first of two global clinical trials designed to test Haduvio (nalbuphine extended-release) — a potential treatment for chronic cough due to idiopathic pulmonary fibrosis (IPF) — is now underway, with the second expected to launch later this year. The initial Phase 3 trial, dubbed OCEAN-1 (NCT07671911), is evaluating the […] The post First global trial now…